Pennine Acute is First NHS Trust to Install iSOFT's e-Prescribing Solution

iSOFTThe Pennine Acute Hospitals NHS Trust has become the first NHS trust to install the e-prescribing and medicines administration (ePMA) solution from iSOFT, a CSC company, after an initial implementation at The Royal Oldham Hospital, under plans to transform and improve patient safety and clinical outcomes across the trust.

ePMA is installed on elderly rehabilitation wards at The Royal Oldham, with doctors, nurses and pharmacists using the software to improve the management of medicines. Following this proof of concept phase, the solution will be rolled out across numerous specialties at the trust's four main hospitals, including A&E, medical assessment unit, oncology and surgical wards, under plans for a trust-wide implementation.

Pennine Acute's associate director of IM&T, Christine Walters, said: "ePMA is a key building block for our strategy to implement a comprehensive electronic patient record. We have undertaken a thorough baseline performance review prior to implementation and we are expecting to able to show benefits relating to patient safety, clinical outcomes and operational efficiency. Early signs are very encouraging."

ePMA is part of a larger programme at Pennine Acute. iSOFT is also delivering a number of integrated clinical solutions, including order communications and results reporting, electronic whiteboards, clinical documentation and a clinical portal.

"This is a clear sign that Pennine continues to gain real value from its partnership with iSOFT and now CSC," said Adrian Stevens, managing director of iSOFT's UK and Ireland business. "Our solution offers substantial benefits in terms of patient safety and patient care and will make a real and lasting difference to clinical staff."

iSOFT ePMA provides new opportunities to improve the communication of medicines related information between medical, nursing and clinical pharmacy teams. Advanced drug formulary management underpinned by clinical and workflow based decision support provides a highly effective environment to help improve a hospital's performance in relation to medicines. In-built reporting and data analysis tools provide executive and management visibility of performance to help proactively address areas of concern or promote good practice.

Proven at large acute and specialist hospitals in Australia and New Zealand, iSOFT ePMA is shown to halve adverse medication errors that can prolong a patient's stay by up to four days, and so block hospital beds and increase costs.

Related news articles:

About CSC
CSC is a global leader in providing technology-enabled business solutions and services. Headquartered in Falls Church, Va., CSC has approximately 93,000 employees and reported revenue of $16.2 billion for the 12 months ended July 1, 2011.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...